Dr. Hossein Ardehali MD, PhD
Assistant Professor, Northwestern University, Feinberg School of Medicine
Member of the Healthcare Council
Council Member Biography
Hossein Ardehali, MD, PhD, is Assistant Professor of Medicine at Feinberg Cardiovascular Institute in Illinois. His specialties include lipid metabolism, preventive cardiology, electrophysiology and heart failure. Dr. Ardehali's basic science research interest is in the areas of reperfusion injury and cardio protection against ischemic injury. He is also involved in several projects involving prevention of coronary artery disease, role of inflammation in atherosclerosis, antiplatelets (like aspirin and Plavix) in heart disease, and statins in inflammation and coronary disease. Dr. Ardehali has used a wide variety of different techniques including confocal microscope, flow cytometry, gene cloning, tissue culture, and protein biochemistry to study the role of mitochondria in cellular protection against ischemia. He is also the Editor of "Cardiology Views and News in the New Millennium". Dr. Ardehali has served as an Instructor at Johns Hopkins University. (This is me - Update Profile)
Employment History
- 2005 - Unspecified
- Assistant Professor, Northwestern University, Feinberg School of Medicine
- 2004 - 2005
- Instructor, Johns Hopkins University
GLG NewsSM Analyses by Hossein Ardehali(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
New studies suggest DES may improve outcome in the setting of AMI
September 19, 2006
NEJM Articles on DES in MI | content.nejm.org
The studies reported in the recent issues of NEJM are significant in that they provide evidence that DES in the setting of AMI with ST elevation may improve outcome. Taxel-eluting stents showed nonsignificant improvement in adverse cardiac events, but sirolimus-eluting stents showed a significant reduction in target vessel revascularization
-
Generic clopidogrel should not alter its use
August 18, 2006
Mixed thoughts on how generic clopidogrel might impact patients, providers | www.theheart.org
There are clear indications to use clopidogrel
Clopidogrel should not be used in every patient with coronary artery disease
Leading institutions connect with Hossein Ardehali through GLG
GLG Study Groups with Hossein Ardehali(?)
| Study Group Name | No. Members |
|---|---|
| Experts in the Leisure & Lodging Council | 4887 |
| Experts in the Automotive Council | 3422 |
| Heart Failure Specialists (US) | 975 |
| Non-Electrophysiologist Cardiologists (US) | 853 |
| Physicians who Treat Hypertension (US) | 792 |
GLG Live Meetings with Hossein Ardehali(?)
Hossein Ardehali has not participated in any GLG Live Meetings.